Genedata (USA), Inc.
One Cranberry Hill, Suite 403
Lexington, MA 02421
Genedata Biopharma Platform Adopted by Genmab to Streamline Biotherapeutics R&D Operations
Genedata E2E software solution to increase speed and efficiency of discovery and development of Genmab’s next-generation cancer therapies Basel, Switzerland ‒ July 9, 2019 ‒ Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced that Genmab, an international biotechnology company specializing in the creation and development of differentiated...
Read More »Strategic Partnership Between Genedata and IDBS Aims to Further Streamline Biopharma Discovery, Development and Manufacturing
The collaboration will enable direct integration of IDBS digital solutions with the Genedata Biopharma Platform, accelerating the discovery and development of next-generation biotherapeutics Basel, Switzerland & Boston, MA, USA—January 12, 2021—Genedata and IDBS, both leading innovators for biopharma digital transformation, have entered into a strategic partnership to create synergies between...
Read More »Genedata Collaborates with AstraZeneca to Boost Impact of Cellular Imaging in Biopharma Drug Discovery
Award-winning Genedata Imagence HCS imaging enterprise software rolled out to AstraZeneca R&D sites globally with the aim of improving the identification of new drug candidates and drug targets Basel, Switzerland — December 17, 2020 — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Genedata Imagence®, its deep learning-based...
Read More »Genedata Automates Biopharma R&D with Seamless Integration of Lab Equipment
Thermo Fisher Scientific–Genedata collaboration agreement enables direct integration of Thermo Fisher’s robotics and automation platforms with the Genedata Biopharma Platform, accelerating the discovery and development of next-generation biotherapeutics Basel, Switzerland – July 14, 2020 – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today...
Read More »Servier Selects Genedata Screener to Contribute to its R&D Digital Transformation
Leading enterprise software will integrate digital innovation efforts at Servier by automating data workflows and enabling R&D collaborators to benefit from scientific data integration and harmonization Basel, Switzerland – June 16, 2020 – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that leading French biopharmaceutical company...
Read More »Genedata Partners with Cergentis to Provide End-to-end Solution for Automating TLA-based Clone Selection
Genedata Selector automates sample management, data analysis and report generation for high-throughput Targeted Locus Amplification (TLA) workflow Basel, Switzerland – April 28, 2020 – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the availability of Genedata Selector® for automating the Targeted Locus Amplification (TLA) data...
Read More »Agenus Implements Genedata End-to-end Biologics Workflow Platform for Immunotherapy R&D
Clinical-stage immuno-oncology company Agenus builds on Genedata’s E2E biopharma discovery system to streamline cancer immunotherapy R&D Basel, Switzerland – December 3, 2019 – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Agenus, a clinical-stage immuno-oncology company developing therapies to fight cancer, has...
Read More »Genedata Expands Partnership with Boehringer Ingelheim to Digitalize Next Generation Cell Line Development
Genedata Selector® deployed to streamline complex cell line development processes Basel, Switzerland – November 7, 2019 – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced an expansion of its collaboration with Boehringer Ingelheim, a research-driven pharmaceutical company, to digitalize and automate complex cell line development...
Read More »Octapharma Adopts Genedata Bioprocess to Develop Next-generation Bio-manufacturing Processes
Leading manufacturer of therapeutic proteins implements Genedata Bioprocess to streamline development and manufacture of biopharmaceuticals Basel, Switzerland – October 29, 2019 – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Octapharma, one of the world’s largest human protein manufacturers, has adopted the Genedata...
Read More »Genedata and Merck Co-Develop A Digital Platform for Translational and Clinical Biomarker Research
In the framework of the collaboration, Genedata delivers fully validated cloud-based enterprise solution for integration, management and analysis of clinical, biomarker, NGS, and digital pathology data from public and clinical studies to enable AI-driven development of next generation therapeutics. Basel, Switzerland – October 23, 2019 – Genedata, the leading provider of enterprise software...
Read More »Eisai Chooses Genedata Screener-® for Fast and Reliable Assay Analysis
Industry’s most widely used platform for screening data analysis accelerates Eisai’s novel drug discovery Basel, Switzerland – October 02, 2019 – Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced that Eisai Co. Ltd (Tokyo) has renewed a multi-year agreement to use Genedata Screener® as its standard screening data analysis platform...
Read More »